No Data
No Data
Veracyte Says At Least 18 Abstracts Focused On Decipher Prostate And Decipher Bladder Genomic Classifiers Will Be Presented At AUA 2025
Veracyte Says Data From Decipher Prostate Genomic Classifier Are Linked to Real-World Data in NCI's SEER Specialized Database Release
Express News | Veracyte Announces Decipher Prostate Genomic Classifier Results Are Linked to Real-World Data in National Cancer Institute’s Seer Specialized Database Release
Express News | Veracyte Inc : Leerink Partners Cuts Target Price to $45 From $50
Press Release: Veracyte to Release First Quarter 2025 Financial Results on May 7, 2025
Craig-Hallum Maintains Veracyte(VCYT.US) With Buy Rating, Maintains Target Price $45